Impact of NRTI backbone on renal, bone and cardiovascular markers in HIV-infected individuals receiving a boosted protease inhibitor

INTRODUCTION: We have previously shown in the SSAT 044 study that unconjugated hyperbilirubinaemia in subjects receiving a boosted protease inhibitor (PI/r) has limited impact on renal, cardiovascular (CV) and bone biomarkers, as well as on neurocognitive performance, relative to those receiving PI/...

Descripción completa

Detalles Bibliográficos
Autores principales: Barber, Tristan, Hill, Andrew, Jagjit Singh, Gurmit, Boffito, Marta, Nelson, Mark, Moyle, Graeme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Poster Sessions – Abstract P030
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224792/
https://www.ncbi.nlm.nih.gov/pubmed/25394069
http://dx.doi.org/10.7448/IAS.17.4.19562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224792/
https://www.ncbi.nlm.nih.gov/pubmed/25394069
http://dx.doi.org/10.7448/IAS.17.4.19562

Ejemplares similares